Subtopic Deep Dive

Blood-Brain Barrier Disruption
Research Guide

What is Blood-Brain Barrier Disruption?

Blood-Brain Barrier Disruption uses focused ultrasound with microbubbles to temporarily open the BBB for enhanced drug delivery to the brain.

This technique combines MR-guided focused ultrasound (MRgFUS) and intravenously injected microbubbles to induce cavitation-mediated BBB permeability. Studies demonstrate safety in primates (McDannold et al., 2012, 577 citations) and efficacy for doxorubicin delivery in rats (Treat et al., 2007, 541 citations). Over 50 papers since 2006 explore applications in Alzheimer's and brain tumors.

15
Curated Papers
3
Key Challenges

Why It Matters

BBB disruption enables targeted therapies for brain tumors and Alzheimer's by overcoming the BBB's barrier to drugs like doxorubicin (Treat et al., 2007). Clinical trials show safe BBB opening in patients with primary brain tumors (Mainprize et al., 2019, 574 citations) and Alzheimer's (Lipsman et al., 2018, 888 citations). This approach improves drug penetration without invasive surgery, as validated in rhesus macaques (McDannold et al., 2012).

Key Research Challenges

Ensuring Long-term Safety

Repeated BBB openings risk sterile inflammation and microhemorrhages (Kovacs-Balint et al., 2016, 447 citations). Primate studies confirm short-term safety but highlight need for chronic monitoring (McDannold et al., 2012). Balancing disruption efficacy with tissue integrity remains unresolved.

Optimizing Cavitation Control

Cavitation activity directly associates with BBB disruption but requires precise acoustic monitoring (McDannold et al., 2006, 439 citations). Variability in microbubble dynamics affects reproducibility across brain regions. Pressure thresholds must minimize off-target effects.

Scaling to Clinical Therapies

Translating rodent successes to humans faces dosimetry differences (Treat et al., 2007). Trials in ALS and tumors show feasibility but limited drug efficacy data (Abrahão et al., 2019, 469 citations; Mainprize et al., 2019). Personalized targeting for deep brain structures is needed.

Essential Papers

1.

Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound

Nir Lipsman, Ying Meng, Allison Bethune et al. · 2018 · Nature Communications · 888 citations

2.

High intensity focused ultrasound in clinical tumor ablation

Yufeng Zhou · 2010 · World Journal of Clinical Oncology · 600 citations

Recent advances in high intensity focused ultrasound (HIFU), which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been ...

3.

Temporary Disruption of the Blood–Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques

Nathan McDannold, Costas Arvanitis, Natalia Vykhodtseva et al. · 2012 · Cancer Research · 577 citations

Abstract The blood–brain barrier (BBB) prevents entry of most drugs into the brain and is a major hurdle to the use of drugs for brain tumors and other central nervous system disorders. Work in sma...

4.

Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study

Todd G. Mainprize, Nir Lipsman, Yuexi Huang et al. · 2019 · Scientific Reports · 574 citations

Abstract The blood-brain barrier (BBB) has long limited therapeutic access to brain tumor and peritumoral tissue. In animals, MR-guided focused ultrasound (MRgFUS) with intravenously injected micro...

5.

Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound

Lisa H. Treat, Nathan McDannold, Natalia Vykhodtseva et al. · 2007 · International Journal of Cancer · 541 citations

Abstract The clinical application of chemotherapy to brain tumors has been severely limited because antitumor agents are typically unable to penetrate an intact blood‐brain barrier (BBB). Although ...

6.

Ultrasound Neuromodulation: A Review of Results, Mechanisms and Safety

Joseph Blackmore, S. K. Shrivastava, Jérôme Sallet et al. · 2019 · Ultrasound in Medicine & Biology · 501 citations

7.

First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound

Agessandro Abrahão, Ying Meng, Maheleth Llinas et al. · 2019 · Nature Communications · 469 citations

Reading Guide

Foundational Papers

Start with McDannold (2012, 577 citations) for primate safety proof and Treat (2007, 541 citations) for drug delivery validation, establishing core MRgFUS-microbubble protocol. Follow with McDannold (2006, 439 citations) on cavitation mechanisms.

Recent Advances

Study Lipsman (2018, 888 citations) for Alzheimer's clinical data and Mainprize (2019, 574 citations) for tumor trials, plus Abrahão (2019, 469 citations) for ALS extension.

Core Methods

MRgFUS with lipid-shelled microbubbles (Definity/Optison) at 0.5-1.5 MPa induces stable cavitation for 4-6 hour BBB opening, confirmed by MRI contrast enhancement and Evans Blue assays (McDannold et al., 2006; 2012).

How PapersFlow Helps You Research Blood-Brain Barrier Disruption

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map core works like Lipsman et al. (2018, 888 citations), revealing clusters around MRgFUS in Alzheimer's. exaSearch uncovers niche safety studies, while findSimilarPapers expands from McDannold et al. (2012) to primate validations.

Analyze & Verify

Analysis Agent employs readPaperContent on Mainprize et al. (2019) to extract clinical feasibility metrics, then verifyResponse (CoVe) cross-checks safety claims against Kovacs-Balint et al. (2016). runPythonAnalysis simulates cavitation thresholds from McDannold et al. (2006) data using NumPy, with GRADE grading for evidence strength in therapeutic trials.

Synthesize & Write

Synthesis Agent detects gaps in chronic safety data across Lipsman (2018) and Abrahão (2019), flagging contradictions in inflammation reports. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, latexCompile for figures, and exportMermaid for cavitation mechanism diagrams.

Use Cases

"Model microbubble cavitation pressure thresholds from McDannold 2006 for safe BBB opening."

Research Agent → searchPapers(cavitation BBB) → Analysis Agent → readPaperContent(McDannold 2006) → runPythonAnalysis(NumPy simulation of acoustic emissions) → matplotlib plot of pressure-BBBD correlation.

"Write LaTeX review of clinical BBB trials in Alzheimer's and tumors."

Synthesis Agent → gap detection(Lipsman 2018, Mainprize 2019) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF) → exportBibtex.

"Find code for ultrasound simulation in BBB disruption papers."

Research Agent → paperExtractUrls(BBB ultrasound) → Code Discovery → paperFindGithubRepo → githubRepoInspect(Focused Ultrasound scripts) → runPythonAnalysis(test cavitation model).

Automated Workflows

Deep Research workflow conducts systematic review of 50+ BBB papers, chaining citationGraph from Lipsman (2018) to generate structured reports on safety profiles. DeepScan applies 7-step analysis with CoVe checkpoints to verify cavitation mechanisms in McDannold (2006). Theorizer builds hypotheses on inflammation mitigation from Kovacs-Balint (2016) and primate data.

Frequently Asked Questions

What defines Blood-Brain Barrier Disruption?

It is the temporary, ultrasound-mediated opening of the BBB using focused ultrasound and microbubbles to enhance brain drug delivery (Lipsman et al., 2018).

What are the main methods?

MR-guided focused ultrasound (MRgFUS) with Definity microbubbles induces cavitation for BBB permeability, monitored via acoustic emissions (McDannold et al., 2006; Mainprize et al., 2019).

What are key papers?

Foundational: McDannold (2012, 577 citations, primate safety); Treat (2007, 541 citations, doxorubicin delivery). Recent: Lipsman (2018, 888 citations, Alzheimer's); Mainprize (2019, 574 citations, tumors).

What open problems exist?

Chronic safety after repeated openings (Kovacs-Balint 2016), precise cavitation dosimetry (McDannold 2006), and translation to non-tumoral deep brain therapies (Abrahão 2019).

Research Ultrasound and Hyperthermia Applications with AI

PapersFlow provides specialized AI tools for Engineering researchers. Here are the most relevant for this topic:

See how researchers in Engineering use PapersFlow

Field-specific workflows, example queries, and use cases.

Engineering Guide

Start Researching Blood-Brain Barrier Disruption with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Engineering researchers